Akari Therapeutics, Plc (AKTX) Stock Price

0.233 ▼ -0.005 (-2.10%)
Open: 0.2588 Vol: 134.86K Day's range: 0.233 - 0.2588 Feb 13, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AKTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.24▼ 0.24▼ 0.24▼ 0.24▼ 0.25▼
MA10 0.25▼ 0.25▼ 0.25▼ 0.24▼ 0.27▼
MA20 0.25▼ 0.25▼ 0.25▼ 0.25▼ 0.47▼
MA50 0.24▼ 0.25▼ 0.25▼ 0.28▼ 0.86▼
MA100 0.25▼ 0.26▼ 0.27▼ 0.51▼ 1.51▼
MA200 0.26▼ 0.27▼ 0.28▼ 0.80▼ 5.31▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ -0.001▼ -0.001▼ 0.003▲ 0.005▲
RSI 43.165▼ 44.679▼ 45.034▼ 37.669▼ 26.529▼
STOCH 28.664     17.660▼ 17.660▼ 39.278     10.808▼
WILL %R -87.748▼ -87.748▼ -87.748▼ -80.033▼ -96.505▼
CCI -84.710     -87.849     -94.204     -13.981     -71.290    
Latest Filters Detected On AKTX
MA $AKTX Price Crossed Below MA(7) Set Alert
▲ GAP $AKTX Open Gap Up %5 Set Alert
▲ GAP $AKTX Open Gap Up %3 Set Alert
▲ GAP $AKTX Open Gap Up %2 Set Alert
CDL $AKTX Marubozu Candlestick Pattern Detected Set Alert
Akari Therapeutics, Plc News
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline
Wednesday, February 11, 2026 06:03 AM
CEO Abizer Gaslightwala discusses the Company’s recent announcement around its ADC pipeline expansion and IP strategyCompany also discusses its ...
Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors
Monday, January 26, 2026 12:45 AM
Company expands its ADC pipeline and patent estate for novel, differentiated ADCs New pipeline candidate AKTX-102 leverages Akari’s proprietary PH1 spliceosome payload and a novel antibody construct ...
Akari Therapeutics to Present at the 2026 Biotech Showcase
Thursday, January 08, 2026 06:15 AM
Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...
AKTX historical stock data
date open high low close volume
13/02/26 0.2588 0.2588 0.233 0.233 134,864
12/02/26 0.2401 0.2566 0.2341 0.238 148,227
11/02/26 0.249 0.2665 0.2283 0.2456 227,066
10/02/26 0.255 0.257 0.2421 0.2421 171,260
09/02/26 0.246 0.26 0.226 0.248 129,600
06/02/26 0.225 0.248 0.221 0.235 165,100
05/02/26 0.222 0.249 0.222 0.225 272,047
04/02/26 0.2285 0.2385 0.2214 0.2301 227,254
03/02/26 0.243 0.25 0.2213 0.2332 76,237
02/02/26 0.245 0.2457 0.2346 0.237 174,979
Quote Details
52wk Low:0.218
52wk High:1.73
Vol:134.86K
Avg Vol(3m):21M
1Y Chng:-75.13%
1M Chng:-19.66%
Add to Watch List
More Information
Index US Composite
Market Cap. 16.96M